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Dear Editor, 
There is little debate that the lymph node yield is an important marker of quality and 
prognosis in colon cancer and that procuring a minimum of 12 is an acceptable standard of 
care, and that decreased survival is associated with  <12 nodes being obtained. (1). The value 
of obtaining more than 12 nodes or optimal absolute node is contentious. Recently, Del 
Paggio et al evaluated the association of lymph node yield with nodal positivity and cancer-
specific survival after curative resection for stages II/III colon cancer, concluding that 
thresholds for optimal survival are associated with yields greater than 12(2). However, the 
authors and other studies have shown the number of nodes examined above 12 does not 
associate with staging, use of adjuvant therapy, or significant survival benefit in colon 
cancer(3). So why strive  for more nodes? 
 
The number of nodes examined depends on many variables, including the surgeon’s 
technique of lymphadenectomy and the pathologist’s meticulous dissection with  specimen. It 
is reasonable to suggest that the extent of resection should be based on anatomical and 
embryological landmarks, not the premise of getting more nodes. This concept is illustrated 
by the “en bloc” total mesorectal excision (TME) in rectal cancer(4). The concept of 
Complete Mesocolic Excision (CME) with Central Vascular Ligation in colon cancer is 
meant to be analogous to the TME but the concepts are not directly transferable. While some 
evidence suggests CME is associated withimproved survival outcomes, it is debatable 
whether this is  related to an increased number of nodes. (6). AS such, considering the the 
increased morbidity with increased nodal yield, , there is insufficient evidence to recommend 
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Perhaps the right answer is to perform a more accurate dissection, not just procure more 
nodes. Techniques to improve nodal assessment and supplement pathological staging, such as 
radioimmunoguided surgery (RIGS) and sentinel lymph node (SNL) mapping have been 
described although their their role remains poorly defined. . The most meaningful tool for 
guiding the optimal resection margins may be intra-operative fluorescence imaging (FI) with 
a fluorophore, such as indocyanine green (ICG). FI allows direct visualization of the tumor 
with its draining nodal basin, the sentinel node(s), and any aberrant nodes outside of the 
planned resection field, thus permitting a more precise  mesenteric lymphadenectomy, 
obviating a reliance on lymph node numbers alone.. FI can also show the watershed areas in 
the mesentery and define the lateral extents of lymphatic spread, allowing a CME-style 
dissection to be completed. This type of  lymphatic mapping may permit improved  
intraoperative cancer-targeting techniques. 
 
The clinical implications for this precision-guided surgery could impact staging, patient 
prognosis, and guide adjuvant therapy recommendations the way simply harvesting more 
nodes could not. Studies are underway to validate these clinical assumptions with FI, and 
technical details are being standardized. In the meantime, ensuring pathological scrutiny of 
our surgery, we must continue to strive for optimal resections based on oncological principles 
to obtain a minimum of 12 nodes for our patients the best outcomes. 
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